Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A phase I trial of HSG4112

Trial Profile

A phase I trial of HSG4112

Recruiting
Phase of Trial: Phase I

Latest Information Update: 28 Jun 2018

At a glance

  • Drugs HSG 4112 (Primary)
  • Indications Obesity
  • Focus Adverse reactions
  • Most Recent Events

    • 28 Jun 2018 New trial record
    • 29 May 2018 According to a Glaceum Inc. media release, the Korean Ministry of Food and Drug Safety (MFDS) approved the IND for the initiation of clinical trials for HSG4112.
    • 28 May 2018 According to a Glaceum Inc. media release, the trial will be conducted at Seoul National University Hospital until the first quarter 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top